Seite auswählen

mylife Diabetescare is offering a new single use safety lancet for taking of blood samples. The innovation consists of a single use release mechanism which retracts the needle into the housing after application, thus preventing accidental multiple use.

mylife Diabetescare is a product and service program for people with diabetes and is administrated by the Swiss company Ypsomed. Ypsomed is active in medical technology and the developer – and manufacturer – of customized injection pens and pen needles for diabetes, growth hormone or infertility therapies.

[ilink url=] link to source (Ärzte Zeitung)[/ilink]